InvestorsHub Logo
Followers 37
Posts 7064
Boards Moderated 1
Alias Born 09/06/2014

Re: livinginsv post# 27250

Sunday, 01/04/2015 7:56:57 AM

Sunday, January 04, 2015 7:56:57 AM

Post# of 30046
I say the Aussies took the Radient job because Charter was thinking about pitching his DR-70 saliva test to investors in China and/or Australia.

Before, Charter's business plan involved buying DR-70 from someone and then re-packaging it as a saliva test. The business plan would be much more profitable if the company could manufacture DR-70 in-house. Charter wanted the IP and any remaining lab equipment because that makes his sales pitch to investors more attractive.

RXPC shareholders were just an annoyance to Charter. You'd think he would at least give them closure but he chose to simply ignore them.

Thanks for that explanation of California law, by the way, living! 2021 isn't that far away, really.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.